United European Gastroenterology, a group of over 30,000 European specialists, returned to Vienna, Austria for the latest UEG Week. At this internationally renowned Congress that draws experts from around the World, we took the opportunity to speak to some of them about the latest developments in IBD. In this series of interviews, we hear from Dr Nik Ding of St. Vincent’s Hospital Melbourne, Australia; Professor Edouard Louis from the University of Liege, Belgium; Dr James Lee from the University of Cambridge, UK as well as Professor Thomas Ochsenkühn from the ISAR Kliniken in Munich, Germany.
Who would you like you hear from? Click on one of the links below to watch one of our expert’s personal IBD insights.
From ongoing unmet needs, to managing treatment non-response, and the potential role of faecal microbiota transplantation in IBD. Dr Nik Ding offers his opinions on these and other important topics in the field of IBD.
How will the treatment of IBD change in the coming years and what role might genetic and biological determinants of prognosis play? These topics and more are discussed by Dr James Lee.
Professor Edouard Louis offers his thoughts not only on the changing treatment strategies and goals of managing Crohn’s disease and ulcerative colitis, but also provides insights into when treatment can be de-escalated and the potential role of biosimilars in managing inflammatory bowel disease.
How does Professor Thomas Ochsenkühn classify his IBD patients and how does he see the future of IBD treatment changing? What is the risk of malignancy among patients with IBD? These questions and other topics of interest are addressed in this series of interesting videos.
Alternatively login via
Back to epgonline.org